TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-12,712 Cr | ₹-540 Cr | ₹-168 Cr | ₹-2,415 Cr | ₹-197 Cr |
What is the latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-12,712 Cr |
| Mar2025 | ₹-540 Cr |
| Mar2024 | ₹-168 Cr |
| Mar2023 | ₹-2,415 Cr |
| Mar2022 | ₹-197 Cr |
How is Cash Flow from Investing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-12,712 Cr | Negative | |
| Mar2025 | ₹-540 Cr | Negative | |
| Mar2024 | ₹-168 Cr | Negative | |
| Mar2023 | ₹-2,415 Cr | Negative | |
| Mar2022 | ₹-197 Cr | - | |
Compare Cash Flow from Investing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹177,266.4 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
| MANKIND PHARMA | ₹97,850.4 Cr | -4.5% | 2.7% | -2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2% |
-6.1% |
33% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses